Modulation of insulin sensitivity by insulin-degrading enzyme

CM González-Casimiro, B Merino… - Biomedicines, 2021 - mdpi.com
Insulin-degrading enzyme (IDE) is a highly conserved and ubiquitously expressed
metalloprotease that degrades insulin and several other intermediate-size peptides. For …

Targeting insulin-degrading enzyme in insulin clearance

MA Leissring, CM González-Casimiro… - International journal of …, 2021 - mdpi.com
Hepatic insulin clearance, a physiological process that in response to nutritional cues
clears~ 50–80% of circulating insulin, is emerging as an important factor in our …

Insulin-degrading enzyme: Paradoxes and possibilities

MA Leissring - Cells, 2021 - mdpi.com
More than seven decades have passed since the discovery of a proteolytic activity within
crude tissue extracts that would become known as insulin-degrading enzyme (IDE) …

Identification of Electrostatic Hotspots at the Binding Interface of Amylin and Insulin-Degrading Enzyme: A Structural and Biophysical Investigation

W Li - 2024 - preprints.org
Amylin, also known as islet amyloid polypeptide (IAPP), is a metabolic homeostasis-related
hormone that is produced and released by the β cells of the pancreas, the same cells that …

The Role of Amyloidogenic Peptides in Disruption of Insulin Secretion and Action

JE Rowles - 2023 - espace.curtin.edu.au
Type 2 Diabetes and Alzheimer's Disease share many common features, including one
examined in this thesis: the build-up of proteins into toxic plaque in vital organs. The thesis …

Amylin, CGRP and the AMY1 receptor: Localisation in the trigeminal ganglia and receptor regulation

TA Rees - 2021 - researchspace.auckland.ac.nz
Calcitonin gene-related peptide (CGRP) is a neuromodulatory peptide that is highly
expressed in the nervous system. It is involved in several physiological and …